NASDAQ · ARGX
argenx SE
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for ARGX has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $7.70 | $9.19 | $6.94 | 9 |
| Mar 2027 | $7.08 | $7.92 | $6.54 | 5 |
| Jun 2027 | $8.27 | $8.90 | $7.83 | 5 |
| Sep 2027 | $9.22 | $9.87 | $8.67 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · Fintel · MarketBeat · Zacks- The Motley Fool · Oct 23, 7:25 AM EDTargenx: 3 Key Takeaways for Long-Term InvestorsProduct net sales reached $1.7 billion, growing 54% year over year.
- The Motley Fool · Oct 23, 4:42 AM EDTargenx (ARGX) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Oct 22, 12:59 PM EDTargenx SE Reports Third Quarter 2026 Financial Results and Business Updateargenx SE reported its third quarter 2026 financial results, highlighted by global product net sales of $1.7 billion for VYVGART, representing 54% year-over-year growth and 13% quarter-over-quarter growth. Total operating income for the three months ended September 30, 2026 was $
- MarketBeat · Oct 22, 12:04 PM EDTWhat argenex (ARGX) Said on Its Q3 Earnings Call2 Ways to Play the Big Pharma Patent Cliffargenex (NASDAQ:ARGX) reported third-quarter 2026 product net sales of $1.7 billion, up 54% from a year earlier and 13% sequentially, as patient growth in generalized myasthenia gravis, or MG, and chronic inflammatory demyelinating polyne
- Zacks · Oct 22, 10:40 AM EDTHRMY or ARGX: Which Is the Better Value Stock Right Now?HRMY vs. ARGX: Which Stock Is the Better Value Option?
- RTTNews · Oct 22, 9:02 AM EDTArgenx Q3 Net Income Rises As VYVGART Sales Increase(RTTNews) – Argenx SE (ARGX) reported on Thursday higher third-quarter net income and product sales, reflecting continued growth of its VYVGART franchise.
- RTTNews · Oct 22, 1:42 AM EDTArgenx Earnings Up In Q3(RTTNews) – argenx SE (ARGX), an immunology innovation company, on Thursday reported higher net income in the third quarter compared with the previous year.
- BNK Invest · Oct 21, 10:57 AM EDTIBB, REGN, NTRA, ARGX: Large Outflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an approximate $200.0 million dollar outflow — that's a 1.8% decrease week over week
- Zacks · Oct 16, 7:35 AM EDTZacks Investment Ideas feature highlights: Cummins, Argenx and PACCARCummins, Argenx and PACCAR offer potential buying opportunities after recent pullbacks, backed by strong earnings growth, improving forecasts and long-term business drivers.
- Zacks · Oct 15, 12:52 PM EDTBest 3 Non-AI Stocks to Buy Now on the Dip Amid the AI Stock SelloffDiving into three great stocks to buy at a discount and hold that are posting impressive earnings and revenue growth outside of the AI boom.
- BNK Invest · Oct 12, 11:52 AM EDTiShares Biotechnology ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an approximate $330.4 million dollar outflow — that's a 3.0% decrease week over week
- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for argenx SE from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.